Northwestern Mutual Wealth Management
FOLD

Northwestern Mutual Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.06K Sell
350
-1,162
-77% -$16.7K ﹤0.01% 3310
2025
Q4 		$21.5K Buy
1,512
+1,162
+332% +$11.4K ﹤0.01% 2719
2025
Q3 		$2.76K Hold
350
– – ﹤0.01% 3310
2025
Q2 		$2.01K Sell
350
-129
-27% -$833 ﹤0.01% 3259
2025
Q1 		$3.91K Buy
479
+25
+6% +$231 ﹤0.01% 3007
2024
Q4 		$4.28K Buy
454
+104
+30% +$1.08K ﹤0.01% 2990
2024
Q3 		$3.74K Hold
350
– – ﹤0.01% 2981
2024
Q2 		$3.47K Hold
350
– – ﹤0.01% 2973
2024
Q1 		$4.12K Hold
350
– – ﹤0.01% 2896
2023
Q4 		$4.97K Hold
350
– – ﹤0.01% 2862
2023
Q3 		$4.26K Hold
350
– – ﹤0.01% 2796
2023
Q2 		$4.4K Buy
+350
New +$4.15K ﹤0.01% 2821
2023
Q1 		– Sell
-20
Closed -$244 – 3445
2022
Q4 		$244 Buy
+20
New +$225 ﹤0.01% 3174
2022
Q2 		– Sell
-12
Closed – – 3272
2022
Q1 		$0 Buy
+12
New +$113 ﹤0.01% 3205

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Northwestern Mutual Wealth Management's FOLD Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Amicus Therapeutics (FOLD) stake by 77% in Q1 2026, selling an estimated $16.7K and leaving 350 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

Northwestern Mutual Wealth Management first reported a position in FOLD in Q1 2022 and has held it in 14 quarters since. The position peaked at $21.5K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Northwestern Mutual Wealth Management held 350 shares of Amicus Therapeutics worth $5.06K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 1,162 Amicus Therapeutics shares in Q1 2026, an estimated $16.7K.
  • Amicus Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3310 holding.
  • Northwestern Mutual Wealth Management first reported a position in Amicus Therapeutics in Q1 2022 and has held it in 14 quarters since.
  • Northwestern Mutual Wealth Management's Amicus Therapeutics position peaked at $21.5K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.